Personalized Cancer Vaccine Succeeds in Major Trial

A groundbreaking personalized mRNA cancer vaccine has passed its first major clinical trial, marking a milestone in the fight against cancer.

The treatment prevented melanoma from returning in patients after surgery, offering new hope for thousands facing the disease.